Stryker vs. Zimmer Biomet vs. J&J in Q2: How 3 spine companies compare

Stryker, Johnson & Johnson and Zimmer Biomet posted their second-quarter financial results for 2024 and data on their spine orthopedic sales.

Advertisement

Here is how they compare:

Stryker

Total sales: $5.4 billion (+8.5%)

Orthopedics: $2.3 billion (+7.9%)

Hips: $428 million (+8.9%)

Knees: $602 million (+7.1%)

Spine: $307 million (+3.8%)

Net gain: $825 million

Zimmer Biomet

Total sales: $1.9 billion (+3.9%)

Hips: $506.6 million (+0.4%)

Knees: $801.1 million (+3.9%)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $469.5 million (+6.1%)

Net earnings: $242.8 million

Johnson & Johnson

Total sales: $22.4 billion (+4.3%)

Orthopedic: $2.3 billion (+2.1%)

Spine, sports and other: $743 million (-3.1%)

Hips: $417 million (+4.9%)

Knees: $394 million (+8.4%)

Net earnings: $4.7 billion

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.